METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
批准号:
3458170
负责人:
ALAN MARSHALL MILLER
金额:
$8.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1993-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Continuous presence of a glycoprotein termed colony stimulating factor
(CSF) is necessary for the in vitro clonal growth of the committed
granulocyte-macrophage progenitor cell (CFU-GM). CSF stimulates the release
of arachidonic acid from membrane phospholipids, and arachidonic acid is
then transformed to products of cyclooxygenation and lipoxygenation.
Inhibition of lipoxygenase and specifically of the synthesis of
leukotrienes C and D (LTC and LTD) blocks CSF-induced colony growth, and
the block can be partially reversed by addition of LTC or LTD.
CFU-GM from a subset of patients with acute non-lymphoblastic leukemia
(ANLL) exhibit resistance to the inhibitory effects of high concentrations
of lipoxygenase inhibitors. This may reflect a release from a normal
regulatory mechanism related to oncogenesis. The metabolism of lipoxygenase
intermediates to LTC and LTD depends on glutathione reductase, glutathione
S-transferase and gamma-glutamyl transpeptidase. The genes for two of these
enzymes have been localized to chromosomes that are frequently involved in
cytogenetic abnormalities associated with ANLL.
The overall objective of the proposed research is to further elucidate the
role of arachidonic acid and glutathione metabolism in normal CSF
stimulated CFU-GM growth and in leukemia by 1) determining the role of
specific critical enzymes of leukotriene and glutathione metabolism in
normal and leukemic myeloid cell; and 2) examining changes in the activity
of those specific enzymes as leukemic cell lines are induced to
differentiate.
To accomplish this, recombinant human CSF, semi-purified bone marrow
progenitor cells from normal and leukemic individuals, and well-
characterized human leukemic cell lines will be used. Enzymes in the
lipoxygenase pathway will be inhibited selectively. Patterns of inhibition
of the leukemic cell lines will be compared with normal and leukemic bone
marrow cells. The content and activity of enzymes which are found to impact
on normal and leukemic colony formation will be quantitated and related to
growth patterns. The results of these studies will enhance our knowledge of
normal and neoplastic regulation and will serve to focus future studies on
the molecular genetics of altered regulation in leukemic cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Histochemical quantitation of gamma-glutamyl transferase in human leukemia cell lines.
人白血病细胞系中γ-谷氨酰转移酶的组织化学定量。
DOI:
10.1177/39.2.1702798
发表时间:
1991
期刊:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
影响因子:
--
作者:
[Kobb,SM, Miller,AM]
通讯作者:
Miller,AM
Regulation of T-lymphopoiesis by arachidonic acid metabolites.
花生四烯酸代谢物调节 T 淋巴细胞生成。
DOI:
--
发表时间:
1989
期刊:
Experimental hematology
影响因子:
2.6
作者:
[Miller,AM, Elfenbein,GJ, Barth,KC]
通讯作者:
Barth,KC
Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro.
体外脂氧合酶途径代谢物对 HL-60 分化的调节。
DOI:
--
发表时间:
1990
期刊:
Cancer research
影响因子:
11.2
作者:
[Miller,AM, Kobb,SM, McTiernan,R]
通讯作者:
McTiernan,R
Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth.
脂氧合酶和谷胱甘肽途径抑制剂对白血病细胞系生长的影响。
DOI:
--
发表时间:
1989
期刊:
The Journal of laboratory and clinical medicine
影响因子:
--
作者:
[Miller,AM, Cullen,MK, Kobb,SM, Weiner,RS]
通讯作者:
Weiner,RS
SWOG JBR10:STUDY OF ADJUVANT CHEMOTHERAPY, VINORELBINE & CISPLATIN, L
-
批准号:6265784
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1999
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
SWOG 9713:CISPLATIN & ETOPOSIDE & CONCURRENT RADIOTHERAPY FOR SMALL C
-
批准号:6309583
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1999
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
SWOG 9713:CISPLATIN & ETOPOSIDE & CONCURRENT RADIOTHERAPY FOR SMALL C
-
批准号:6265793
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1999
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
SWOG S9704:COMPARING HIGH DOSE CHEMORADIOTHERAPY & AUTOLOGOUS CELL TR
-
批准号:6265790
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1999
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
CD34 SELECTED PERIPHERAL BLOOD PROGENITOR CELLS W/ IMMUNOBLATION
-
批准号:6265779
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1999
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
PHASE I/II STUDY OF PATIENTS W/ RELAPSED LYMPHOMA TREATED W/ CYCLOPHOSPHAMIDE
-
批准号:6253129
-
项目类别:
-
资助金额:$1.16万
-
财政年份:1997
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
-
批准号:3458167
-
项目类别:
-
资助金额:$8.43万
-
财政年份:1987
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
-
批准号:3458166
-
项目类别:
-
资助金额:$8.68万
-
财政年份:1987
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
-
批准号:3458169
-
项目类别:
-
资助金额:$8.62万
-
财政年份:1987
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
-
批准号:3458168
-
项目类别:
-
资助金额:$8.45万
-
财政年份:1987
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
TULANE NATINAL PRIMATE RESEARCH CENTER
-
批准号:7066674
-
项目类别:
-
资助金额:$741.42万
-
财政年份:1978
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
TULANE NATINAL PRIMATE RESEARCH CENTER
-
批准号:7472672
-
项目类别:
-
资助金额:$53.03万
-
财政年份:1978
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
CD34 SELECTED PERIPHERAL BLOOD PROGENITOR CELLS W/ IMMUNOBLATION
-
批准号:6309569
-
项目类别:
-
资助金额:$1.12万
-
财政年份:--
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
SWOG JBR10:STUDY OF ADJUVANT CHEMOTHERAPY, VINORELBINE & CISPLATIN, L
-
批准号:6309574
-
项目类别:
-
资助金额:$1.12万
-
财政年份:--
-
负责人:ALAN MARSHALL MILLER
-
依托单位:
SWOG S9704:COMPARING HIGH DOSE CHEMORADIOTHERAPY & AUTOLOGOUS CELL TR
-
批准号:6309580
-
项目类别:
-
资助金额:$1.12万
-
财政年份:--
-
负责人:ALAN MARSHALL MILLER
-
依托单位: